153 related articles for article (PubMed ID: 25677387)
1. Rapid detection and destruction of squamous cell carcinoma of the head and neck by nano-quadrapeutics.
Lukianova-Hleb EY; Lapotko DO
Head Neck; 2015 Oct; 37(10):1547-55. PubMed ID: 25677387
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of quadrapeutics versus chemoradiation in head and neck carcinoma xenograft model.
Lukianova-Hleb EY; Kim YS; Aryasomayajula B; Boulikas T; Phan J; Hung MC; Torchilin VP; O'Neill BE; Lapotko DO
Am J Cancer Res; 2015; 5(12):3534-47. PubMed ID: 26885444
[TBL] [Abstract][Full Text] [Related]
3. On-demand intracellular amplification of chemoradiation with cancer-specific plasmonic nanobubbles.
Lukianova-Hleb EY; Ren X; Sawant RR; Wu X; Torchilin VP; Lapotko DO
Nat Med; 2014 Jul; 20(7):778-784. PubMed ID: 24880615
[TBL] [Abstract][Full Text] [Related]
4. PET monitoring of therapy response in head and neck squamous cell carcinoma.
Schöder H; Fury M; Lee N; Kraus D
J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
[TBL] [Abstract][Full Text] [Related]
5. Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma.
Hagemann J; Jacobi C; Gstoettner S; Welz C; Schwenk-Zieger S; Stauber R; Strieth S; Kuenzel J; Baumeister P; Becker S
J Vis Exp; 2018 Apr; (134):. PubMed ID: 29733308
[TBL] [Abstract][Full Text] [Related]
6. FDG PET/CT in Patients With Head and Neck Squamous Cell Carcinoma After Primary Surgical Resection With or Without Chemoradiation Therapy.
Taghipour M; Sheikhbahaei S; Wray R; Agrawal N; Richmon J; Kang H; Subramaniam RM
AJR Am J Roentgenol; 2016 May; 206(5):1093-100. PubMed ID: 26999264
[TBL] [Abstract][Full Text] [Related]
7. [Study results of primary therapy for head and neck tumors : Highlights of the 2016 ASCO Annual Meeting].
Gliese A; Busch CJ; Knecht R
HNO; 2016 Oct; 64(10):717-22. PubMed ID: 27624903
[TBL] [Abstract][Full Text] [Related]
8. Treatment outcomes in veterans with HPV-positive head and neck cancer.
Feinstein AJ; Shay SG; Chang E; Lewis MS; Wang MB
Am J Otolaryngol; 2017; 38(2):188-192. PubMed ID: 28342482
[TBL] [Abstract][Full Text] [Related]
9. Functional MRI for the prediction of treatment response in head and neck squamous cell carcinoma: potential and limitations.
King AD; Thoeny HC
Cancer Imaging; 2016 Aug; 16(1):23. PubMed ID: 27542718
[TBL] [Abstract][Full Text] [Related]
10. Preoperative simultaneous fractionated cisplatin and radiation therapy in the treatment of advanced operable stage III and IV squamous cell carcinoma of the head and neck.
Davis MA; Tyrrell J; Slotman GJ; Sudhindra R; Sachdeva K; Fanelle J; Smith G; Wurzer JV; Cassir J; Nazha NT;
Am J Surg; 2015 Mar; 209(3):575-9. PubMed ID: 25557972
[TBL] [Abstract][Full Text] [Related]
11. Nomograms predicting long-term overall survival and cancer-specific survival in head and neck squamous cell carcinoma patients.
Ju J; Wang J; Ma C; Li Y; Zhao Z; Gao T; Ni Q; Sun M
Oncotarget; 2016 Aug; 7(32):51059-51068. PubMed ID: 27419636
[TBL] [Abstract][Full Text] [Related]
12. Telomerase-specific oncolytic adenovirus: antitumor effects on radiation-resistant head and neck squamous cell carcinoma cells.
Takahashi H; Hyakusoku H; Horii C; Takahashi M; Nishimura G; Taguchi T; Kondo N; Sakakibara A; Urata Y; Sano D
Head Neck; 2014 Mar; 36(3):411-8. PubMed ID: 23728900
[TBL] [Abstract][Full Text] [Related]
13. [Immunotherapy for head and neck squamous cell carcinoma].
Chen J; Chen M; Wu HT
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 52(2):143-147. PubMed ID: 28219181
[TBL] [Abstract][Full Text] [Related]
14. Analysis of dysphagia in advanced-stage head-and-neck cancer patients: impact on quality of life and development of a preventive swallowing treatment.
Carmignani I; Locatello LG; Desideri I; Bonomo P; Olmetto E; Livi L; Le Saec O; Coscarelli S; Mannelli G
Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2159-2167. PubMed ID: 29978259
[TBL] [Abstract][Full Text] [Related]
15. Squamous cell carcinoma-associated antigens used in novel strategies for the detection and treatment of minimal residual head and neck cancer.
van Dongen GA; Brakenhoff RM; ten Brink CT; van Gog FB; de Bree R; Quak JJ; Snow GB
Anticancer Res; 1996; 16(4C):2409-13. PubMed ID: 8816843
[TBL] [Abstract][Full Text] [Related]
16. microRNAs are important players in head and neck carcinoma: a review.
Janiszewska J; Szaumkessel M; Szyfter K
Crit Rev Oncol Hematol; 2013 Dec; 88(3):716-28. PubMed ID: 23948550
[TBL] [Abstract][Full Text] [Related]
17. Gold nanorod-sphingosine kinase siRNA nanocomplexes: a novel therapeutic tool for potent radiosensitization of head and neck cancer.
Masood R; Roy I; Zu S; Hochstim C; Yong KT; Law WC; Ding H; Sinha UK; Prasad PN
Integr Biol (Camb); 2012 Feb; 4(2):132-41. PubMed ID: 22159374
[TBL] [Abstract][Full Text] [Related]
18. [Current oncologic concepts and emerging techniques for imaging of head and neck squamous cell cancer].
Sadick M; Schoenberg SO; Hoermann K; Sadick H
Laryngorhinootologie; 2012 Mar; 91 Suppl 1():S27-47. PubMed ID: 22456918
[TBL] [Abstract][Full Text] [Related]
19. Clinical Practice in PET/CT for the Management of Head and Neck Squamous Cell Cancer.
Goel R; Moore W; Sumer B; Khan S; Sher D; Subramaniam RM
AJR Am J Roentgenol; 2017 Aug; 209(2):289-303. PubMed ID: 28731808
[TBL] [Abstract][Full Text] [Related]
20. [Immunotherapeutic studies of head and neck tumors : Highlights of the 2016 ASCO Annual Meeting].
Busch CJ; Laban S; Knecht R; Hoffmann TK
HNO; 2016 Oct; 64(10):708-16. PubMed ID: 27604282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
